American Psychiatric Association Releases New Practice Guideline On Schizophrenia Treatment
On September 1, 2020, the American Psychiatric Association (APA) released a new practice guideline for treating people with schizophrenia. The guideline recommends that people with schizophrenia have a documented, comprehensive, and person-centered treatment plan that includes evidence-based non-pharmacological and pharmacological treatments. The guideline also recommends or suggests options for treating side effects associated with antipsychotic medication. The goal is to reduce the mortality, morbidity, and significant psychosocial and health consequences of schizophrenia.
The pharmacotherapy recommendations include the following:
Antipsychotic medication with monitoring for effectiveness and side effects; continuation of medication for those whose symptoms have improved;
Clozapine . . .
